Leap Therapeutics Inc. (LPTX)
0.42
-0.04 (-9.35%)
At close: Mar 03, 2025, 3:59 PM
0.42
0.05%
After-hours: Mar 03, 2025, 05:47 PM EST
Leap Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -81.41M | -54.6M | -40.59M | -27.51M | -32.9M | -23.14M | -29.73M | -25.63M | -21.1M | -25.45M | -18.32M | -7.76M |
| Depreciation & Amortization | 15K | 16K | 29K | 34K | 47K | 49K | 48K | 25K | 474K | 657K | 640K | 649K |
| Stock-Based Compensation | 5.13M | 5.18M | 3.48M | 2.62M | 3.89M | 3.47M | 5.6M | 45K | 1.72M | 1.66M | 2.65M | 241K |
| Other Working Capital | 497K | -1.6M | -2.89M | 1.61M | 247K | 503K | 1.2M | -3.27M | -1.05M | 850K | 440K | 266K |
| Other Non-Cash Items | 30.01M | 855K | 527K | 634K | 732K | -7.3M | -194K | 1.23M | 14K | 4.54M | 4.45M | -1.04M |
| Deferred Income Tax | n/a | 152K | 379K | -738K | -3K | 20K | -158K | n/a | 370K | -271K | 85K | 93K |
| Change in Working Capital | 2.51M | -651K | 1.01M | -990K | 1.33M | 871K | 2.29M | -1.01M | -1.05M | 850K | 558K | 266K |
| Operating Cash Flow | -43.75M | -49.04M | -35.16M | -25.96M | -26.9M | -26.03M | -22.14M | -25.34M | -19.58M | -18.02M | -9.94M | -7.55M |
| Capital Expenditures | n/a | n/a | n/a | n/a | -100K | n/a | -64K | -144K | -12K | -227K | -116K | -130K |
| Acquisitions | 50.36M | n/a | n/a | 25K | 15K | n/a | n/a | n/a | 61K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -418K | -35.39M | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30.05M | 53K | n/a | n/a |
| Other Investing Acitivies | -1.39M | n/a | n/a | 25K | 15K | n/a | -64K | n/a | 9K | -1.24M | 2K | -6K |
| Investing Cash Flow | 48.97M | n/a | n/a | 25K | -85K | n/a | -64K | -144K | 29.69M | -36.8M | -114K | -136K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 750K | 25.9M | 4.4M | n/a | n/a | n/a |
| Common Stock Repurchased | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | -303K | -359K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -29K | -210K | 813K | 25.48M | -437K | 872K | -2.15M | -282K | -4.38M | 198K | n/a | 2.41M |
| Financial Cash Flow | -30K | -210K | 98.03M | 74M | 14.82M | 15.91M | 47.76M | 25.62M | 16K | 46.89M | 13.75M | 12.29M |
| Net Cash Flow | 5.14M | -49.42M | 62.84M | 48.18M | -12.39M | -9.45M | 24.94M | 388K | 10.1M | -8.13M | 3.67M | 4.6M |
| Free Cash Flow | -43.75M | -49.04M | -35.16M | -25.96M | -27M | -26.03M | -22.2M | -25.48M | -19.59M | -18.24M | -10.05M | -7.68M |